Masimo Corporation
Masimo Terminates Old Credit Agreement and Enters New One
Summary
On December 1, 2025, Masimo Corporation terminated its existing Credit Agreement and entered into a new Credit Facility totaling $1 billion, consisting of a $250 million Term Loan and a $750 million Revolver, with an option to increase borrowing capacity by up to $400 million. The new Credit Facility provides for an unsecured term loan and revolving commitments, with interest rates based on the Alternate Base Rate or Term SOFR plus a spread. The proceeds are used to finance the refinancing and for general corporate purposes. The new agreement replaces the terminated credit agreement and includes financial covenants and customary covenants. An unused fee is also applicable to the unutilized portion of the Revolver.
Profitelligence Alerts
Get alerts for MASI
Be first to know when Masimo Corporation files with the SEC.
Filing Categories
Advertisement
About Masimo Corporation
Masimo Corporation is a global leader in noninvasive monitoring technologies, specifically focusing on developing innovative medical devices that improve patient outcomes and reduce the cost of care. The company's flagship product line includes advanced signal processing pulse oximetry devices, which are pivotal in accurately measuring oxygen levels, pulse rate, and other vital signals without the need for invasive procedures. Masimo's technology is widely adopted across various healthcare settings including hospitals, outpatient treatment centers, and alternative care sites, enhancing patient monitoring and aiding clinicians in detecting potential health issues more efficiently. Besides, Masimo’s products are recognized for their precision and reliability, demonstrating robustness even in challenging clinical environments where motion and low perfusion can affect monitoring accuracy. The corporation is committed to expanding its technological suite, covering a spectrum of health monitoring solutions that contribute to improved healthcare practices globally. Based in Irvine, California, Masimo's ongoing innovation continues to set benchmarks in the healthcare industry, influencing a wide range of sectors from emergency care to surgical and critical care monitoring.
Official SEC Documents
Advertisement